APT Medical Inc. (688617SS) DCF Valuation

APT Medical Inc. (688617.SS) Évaluation DCF

CN | Healthcare | Medical - Devices | SHH
APT Medical Inc. (688617SS) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

APT Medical Inc. (688617.SS) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Évaluez les perspectives financières d'APT Medical Inc. comme un expert! Ce calculatrice DCF (688617SS) vous fournit des données financières pré-remplies et une pleine flexibilité pour modifier la croissance des revenus, le WACC, les marges et d'autres hypothèses essentielles pour s'aligner sur vos prévisions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 404.0 479.4 828.7 1,216.0 1,650.2 2,368.0 3,397.9 4,875.7 6,996.4 10,039.4
Revenue Growth, % 0 18.68 72.85 46.74 35.71 43.49 43.49 43.49 43.49 43.49
EBITDA 106.3 143.2 256.2 453.0 672.4 781.9 1,122.0 1,610.0 2,310.2 3,315.1
EBITDA, % 26.31 29.87 30.92 37.25 40.75 33.02 33.02 33.02 33.02 33.02
Depreciation 15.3 20.7 34.5 51.5 67.9 97.7 140.3 201.3 288.8 414.4
Depreciation, % 3.8 4.33 4.17 4.23 4.11 4.13 4.13 4.13 4.13 4.13
EBIT 91.0 122.5 221.7 401.5 604.5 684.2 981.7 1,408.7 2,021.5 2,900.7
EBIT, % 22.52 25.54 26.75 33.02 36.63 28.89 28.89 28.89 28.89 28.89
Total Cash 73.5 120.3 1,223.4 1,132.2 1,336.4 1,503.1 2,156.9 3,095.0 4,441.2 6,372.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 47.1 43.7 34.0 47.2 41.8
Account Receivables, % 11.65 9.12 4.1 3.88 2.53
Inventories 142.8 145.3 263.2 337.9 328.0 687.1 986.0 1,414.8 2,030.2 2,913.2
Inventories, % 35.36 30.3 31.77 27.79 19.87 29.02 29.02 29.02 29.02 29.02
Accounts Payable 11.0 8.4 21.1 41.2 42.7 61.6 88.4 126.9 182.1 261.3
Accounts Payable, % 2.73 1.76 2.55 3.39 2.59 2.6 2.6 2.6 2.6 2.6
Capital Expenditure -67.6 -44.2 -167.4 -143.2 -202.0 -332.3 -476.8 -684.2 -981.8 -1,408.8
Capital Expenditure, % -16.73 -9.22 -20.2 -11.78 -12.24 -14.03 -14.03 -14.03 -14.03 -14.03
Tax Rate, % 10.47 10.47 10.47 10.47 10.47 10.47 10.47 10.47 10.47 10.47
EBITAT 82.2 111.9 208.0 363.8 541.2 623.6 894.9 1,284.1 1,842.6 2,644.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -148.9 86.8 -20.4 204.4 423.9 -57.6 221.8 318.3 456.8 655.5
WACC, % 5.31 5.31 5.31 5.31 5.31 5.31 5.31 5.31 5.31 5.31
PV UFCF
SUM PV UFCF 1,295.3
Long Term Growth Rate, % 3.50
Free cash flow (T + 1) 678
Terminal Value 37,464
Present Terminal Value 28,923
Enterprise Value 30,219
Net Debt -1,187
Equity Value 31,405
Diluted Shares Outstanding, MM 98
Equity Value Per Share 321.28

What You Will Receive

  • Authentic APT Medical Financial Data: Pre-loaded with historical and projected data for accurate analysis.
  • Completely Customizable Template: Easily adjust key parameters such as revenue growth, WACC, and EBITDA %.
  • Instant Calculations: Watch the intrinsic value of APT Medical update in real-time as you make changes.
  • Expert Valuation Tool: Tailored for investors, analysts, and consultants who require precise DCF outcomes.
  • User-Centric Layout: Straightforward design and clear guidance suitable for all skill levels.

Key Features

  • Pre-Loaded Data: APT Medical Inc.'s historical financial statements and pre-filled forecasts.
  • Fully Adjustable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Instant Results: Experience real-time recalculations of APT Medical Inc.'s intrinsic value.
  • Clear Visual Outputs: Dashboard charts provide clear presentations of valuation results and key metrics.
  • Built for Accuracy: A professional-grade tool tailored for analysts, investors, and finance professionals.

How It Operates

  • Download: Obtain the pre-configured Excel file containing APT Medical Inc.’s (688617SS) financial data.
  • Customize: Modify projections such as revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: Watch the intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and compare results without delay.
  • Make Decisions: Leverage the valuation insights to shape your investment strategy.

Why Opt for APT Medical Inc. Calculator?

  • Precise Data: Utilize real financials from APT Medical Inc. to ensure trustworthy valuation outcomes.
  • Tailorable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Efficiency Boost: Built-in calculations save you the hassle of starting from the ground up.
  • Expert Tool: Crafted for investors, analysts, and consultants in the medical field.
  • Easy to Use: User-friendly design and guided steps make it accessible for everyone.

Who Can Benefit from APT Medical Inc. (688617SS)?

  • Investors: Empower your investment choices with a comprehensive valuation tool tailored for healthcare.
  • Financial Analysts: Streamline your analysis process with a customizable DCF model designed specifically for the medical sector.
  • Consultants: Efficiently modify the template for client briefs or presentations in the healthcare industry.
  • Healthcare Enthusiasts: Enhance your grasp of valuation methodologies with case studies from real-world medical scenarios.
  • Educators and Students: Leverage this resource as a hands-on tool for finance and healthcare education.

Contents of the APT Medical Template

  • Preloaded APT Medical Data: Historical and forecasted financial metrics, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Advanced sheets for determining intrinsic value and Weighted Average Cost of Capital.
  • Customizable Inputs: Yellow-highlighted cells for modifying revenue growth, tax rates, and discount rates.
  • Financial Statements: Detailed annual and quarterly financial reports for in-depth analysis.
  • Key Ratios: Metrics for profitability, leverage, and efficiency to assess performance.
  • Dashboard and Charts: Visual representations of valuation results and underlying assumptions.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

No products were found matching.